Viscomicrosurgery: The Use of a New Fraction of the Sodium Salt of Hyaluronate

  • Riccardo Neuschüler
  • Vito Gasparri
  • Diego Girardi
Conference paper
Part of the FIDIA Research Series book series (FIDIA, volume 2)


Balazs (1950) first had the idea of using hyaluronic acid in ocular surgery. He was struck by the notable morphological similarity of this substance to the vitreous. The first preparation, extracted from the bovine eye, and with a low molecular weight (Etamucin) was, in fact, used as a substitute for the vitreous; but because of the serious reactions that it caused, its use was only tentative.


Hyaluronic Acid Retinal Detachment Intraocular Lens Human Umbilical Cord Sodium Hyaluronate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Algvere P (1971): Intravitreal implantation of a high-molecular hyaluronic acid in surgery for retinal detachment. Acta Ophthamol 49: 975–976Google Scholar
  2. Balazs EA, Freeman MI, Klön R, Meyer-Schwickirath G, Regnault E, Sweeney DB (1972): Hyaluronic acid and replacement of vitreous and aqueous humor. Secondary Detachment of the Retina. Mod Probl Ophthal 10: 3–21.Google Scholar
  3. Binkhorst CD (1981): Advantages and disadvantages of intracamerular Na-hyaluronate (Healon) in intraocular lens surgery. Documenta Ophthalmologica, 50, (2): 233–236PubMedCrossRefGoogle Scholar
  4. Body BF (1981): What is Healon? Is it really the most important substance to come along in cataract surgery since alphachymotrypsin? What is its contribution to penetrating keratoplasty, intraocular lens implant surgery and dry eyes? Highlights of Ophthalmology, 9, (12): 1–5Google Scholar
  5. Comper WD, Laurent TC (1978): Physiological function of connective tissue polysaccharides. Phys Rev, 58, (1): 255–315Google Scholar
  6. Dessì P (1976): Relazione tossicologica per il Ministero della Sanità. Istituto Farmacocinetica e Tossicologia dell’Università di Bologna. datata 13/7/1976.Google Scholar
  7. Edmund J (1974): Vitreous substitute in the treatment of retinal detachment. Limitations and Prospects for Retinal Surgery. Mod Probl Ophthal, 12: 370–377Google Scholar
  8. Gnad HD (1979): Partial vitreous substitution with Ringer’s solution or sodium hyaluronate. Ophthalmic Res, 11: 108–122CrossRefGoogle Scholar
  9. Graue EL, Polack FM, Balazs EA (1980): The protective effect of Na-hyaluronate to corneal endothelium. Exp Eye Res, 31: 119–127PubMedCrossRefGoogle Scholar
  10. Kanski JJ (1975): Intravitreal hyaluronic acid injection. A long-term clinical evaluation. Brit J Ophthal 59: 255–256PubMedCrossRefGoogle Scholar
  11. Klöti R (1972): Hyaluronsäure als Glaskörpersubstituent. Ophthalmologica, 165: 351–359PubMedCrossRefGoogle Scholar
  12. Miller D, O’Connor P, Williams J. (1977): Use of Na-hyaluronate during intraocular lens implantation in rabbits. Ophthalmic Surgery, 8, (6): 58–61PubMedGoogle Scholar
  13. Norm M (1981): Preoperative protection of cornea and conjunctiva. Acta Ophthalmologica, 59: 587:594Google Scholar
  14. Pape LG, Balazs EA: Final report on the use of Healon in glaucoma visco-surgery. Personal communication.Google Scholar
  15. Polack FM, Demong T, Santaella H (1981): Sodium hyaluronate (Healon) in Keratoplasty and I01 implantation. Ophthalmology, 88: 425–431PubMedGoogle Scholar
  16. Pruett RC, Schepens CL, Swann DA (1979): Hyaluronic acid vitreous substitute. A six-year clinical evaluation. Arch Ophthalmol, 97: 2325–2330.PubMedCrossRefGoogle Scholar
  17. Razemon PMM, Turut P, Capier MJ (1972): L’acide hyaluronique dans les traumatismes délabrants du globe. Bulletin des sociétés d’Ophthalmologie de France, 72, (11): 105–107Google Scholar
  18. Regnault F, Bregeat P (1974): Treatment of severe cases of retinal detachment with highly viscous hyaluronic acid. Limitations and Prospects for Retinal Surgery. Mod Probl Ophthal, 12: 378–383.Google Scholar
  19. Richter W (1974): Non immunogenicity of purified hyaluronic acid preparations tested by passive cutaneous anaphylaxis. Int Arch Allergy. 47: 211–217PubMedCrossRefGoogle Scholar
  20. Richter AW, Ryde EM, Zatterstrom EO (1979): Non immunogenicity of a purified sodium hyaluronate preparation in man. Int Archs Appl Immun 59: 45–48.CrossRefGoogle Scholar
  21. Stanifer R, Kretzer F, Mehta R (1981): Effect of Healon on intraocular pressure, corneal thickness, and endothelial morphology in the rabbit. Investigative Opthalmology & Visual Science, 20, (3 Suppl.): 230.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • Riccardo Neuschüler
    • 1
  • Vito Gasparri
    • 1
  • Diego Girardi
    • 1
  1. 1.Divisione OculisticaOspedale FatebenefratelliRomaItaly

Personalised recommendations